CTNM
Price
$11.50
Change
+$0.51 (+4.64%)
Updated
Sep 5 closing price
Capitalization
322.48M
60 days until earnings call
MREO
Price
$1.77
Change
+$0.04 (+2.31%)
Updated
Sep 5 closing price
Capitalization
281.6M
73 days until earnings call
Interact to see
Advertisement

CTNM vs MREO

Header iconCTNM vs MREO Comparison
Open Charts CTNM vs MREOBanner chart's image
Contineum Therapeutics
Price$11.50
Change+$0.51 (+4.64%)
Volume$121.17K
Capitalization322.48M
Mereo BioPharma Group
Price$1.77
Change+$0.04 (+2.31%)
Volume$1.01M
Capitalization281.6M
CTNM vs MREO Comparison Chart in %
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. MREO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Buy and MREO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CTNM: $11.50 vs. MREO: $1.77)
Brand notoriety: CTNM and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 45% vs. MREO: 39%
Market capitalization -- CTNM: $322.48M vs. MREO: $281.6M
CTNM [@Biotechnology] is valued at $322.48M. MREO’s [@Biotechnology] market capitalization is $281.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than MREO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 2 TA indicator(s) are bullish while MREO’s TA Score has 4 bullish TA indicator(s).

  • CTNM’s TA Score: 2 bullish, 4 bearish.
  • MREO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MREO is a better buy in the short-term than CTNM.

Price Growth

CTNM (@Biotechnology) experienced а +10.05% price change this week, while MREO (@Biotechnology) price change was +3.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CTNM is expected to report earnings on Nov 05, 2025.

MREO is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($322M) has a higher market cap than MREO($282M). CTNM YTD gains are higher at: -21.502 vs. MREO (-49.429). MREO has higher annual earnings (EBITDA): -47.49M vs. CTNM (-57.1M). CTNM has more cash in the bank: 175M vs. MREO (56.1M). MREO has less debt than CTNM: MREO (601K) vs CTNM (5.75M). MREO has higher revenues than CTNM: MREO (500K) vs CTNM (0).
CTNMMREOCTNM / MREO
Capitalization322M282M114%
EBITDA-57.1M-47.49M120%
Gain YTD-21.502-49.42944%
P/E Ratio26.40N/A-
Revenue0500K-
Total Cash175M56.1M312%
Total Debt5.75M601K957%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTNMMREO
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 27 days ago
89%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGFH32.00N/A
N/A
Foresight Financial Group Inc.
HINOF2.54N/A
N/A
Hino Motors Ltd.
SHNWF5.33N/A
N/A
Schroders Plc.
VAUCF0.09N/A
-0.37%
Viva Gold Corp.
SMEGF101.85-3.21
-3.06%
Siemens Energy AG

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and CCCC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+4.64%
CCCC - CTNM
29%
Poorly correlated
+1.87%
VYGR - CTNM
28%
Poorly correlated
+9.28%
DYN - CTNM
28%
Poorly correlated
+7.40%
RGNX - CTNM
27%
Poorly correlated
+3.08%
MREO - CTNM
27%
Poorly correlated
+2.31%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with RARE. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+2.31%
RARE - MREO
69%
Closely correlated
+1.73%
TRDA - MREO
44%
Loosely correlated
+1.34%
CRNX - MREO
39%
Loosely correlated
+3.97%
NRIX - MREO
38%
Loosely correlated
+8.66%
SYRE - MREO
35%
Loosely correlated
+0.06%
More